Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:0
|
作者
Haşim Boyacı
Hale Maral
Gupse Turan
İlknur Başyiğit
Meltem Ö. Dillioğlugil
Füsun Yıldız
Melih Tugay
Ayşe Pala
Cengiz Erçin
机构
[1] Kocaeli University School of Medicine,Department of Chest Diseases
[2] Kocaeli University School of Medicine,Department of Biochemistry
[3] Kocaeli University School of Medicine,Department of Pathology
[4] Kocaeli University School of Medicine,Department of Pediatric Surgery
[5] Kocaeli TIP Fakültesi,undefined
来源
Molecular and Cellular Biochemistry | 2006年 / 281卷
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
暂无
中图分类号
学科分类号
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague–Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin + erdosteine (BLM + ERD), and saline alone (control). The BLM and BLM + ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM + ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM + ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 ± 0.15, 0.11 ± 0.02, and 0.087± 0.03 nmol/mg protein in BLM, BLM + ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 ± 0.06, 0.60 ± 0.09, and 0.56± 0.1 μmol/mg protein in BLM, BLM + ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 ± 12.4, 253.2± 25.2, and 287.9± 34.4 nmol/mg protein) (SOD levels were 1.42± 0.12, 1.75± 0.17, and 1.89± 0.09 U/mg protein) in BLM, BLM + ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:8
相关论文
共 50 条
  • [1] Effects of erdosteine on bleomycin-induced lung fibrosis in rats
    Boyaci, H
    Maral, H
    Turan, G
    Basyigit, I
    Dillioglugil, MÖ
    Yildiz, F
    Tugay, M
    Pala, A
    Erçin, C
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 281 (1-2) : 129 - 137
  • [2] Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats
    Yildirim, Z
    Turkoz, Y
    Kotuk, M
    Armutcu, F
    Gurel, A
    Iraz, M
    Ozen, S
    Aydogdu, I
    Akyol, O
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 11 (02): : 156 - 165
  • [3] Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats
    Sogut, S
    Ozyurt, H
    Armutcu, F
    Kart, L
    Iraz, M
    Akyol, O
    Ozen, S
    Kaplan, S
    Temel, I
    Yildirim, Z
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 213 - 220
  • [4] Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats:: erdosteine and N-acetylcysteine
    Yidirim, Z
    Kotuk, M
    Iraz, M
    Kuku, I
    Ulu, R
    Armutcu, F
    Ozen, S
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (05) : 367 - 373
  • [5] Preventive Effect of Chrysin on Bleomycin-Induced Lung Fibrosis in Rats
    Kilic, Talat
    Ciftci, Osman
    Cetin, Asli
    Kahraman, Hasan
    INFLAMMATION, 2014, 37 (06) : 2116 - 2124
  • [6] Attenuation of bleomycin-induced lung fibrosis in rats by mesna
    El-Medany, A
    Hagar, HH
    Moursi, M
    At Muhammed, R
    El-Rakhawy, FI
    El-Medany, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 509 (01) : 61 - 70
  • [7] Protective and Therapeutic Effect of Apocynin on Bleomycin-Induced Lung Fibrosis in Rats
    Kilic, Talat
    Parlakpinar, Hakan
    Taslidere, Elif
    Yildiz, Sedat
    Polat, Alaadin
    Vardi, Nigar
    Colak, Cemil
    Ermis, Hilal
    INFLAMMATION, 2015, 38 (03) : 1166 - 1180
  • [8] Preventive and early therapeutic effects of β-Glucan on the bleomycin-induced lung fibrosis in rats
    Iraz, M.
    Bilgic, S.
    Samdanci, E.
    Ozerol, E.
    Tanbek, K.
    Iraz, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (08) : 1505 - 1516
  • [9] Time course of bleomycin-induced lung fibrosis
    Izbicki, G
    Segel, MJ
    Christensen, TG
    Conner, MW
    Breuer, R
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2002, 83 (03) : 111 - 119
  • [10] Apigenin protects against bleomycin-induced lung fibrosis in rats
    Chen, Ling
    Zhao, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (01) : 230 - 234